Singapore: FAQs on transfer pricing implications of COVID-19
Singapore: FAQs on transfer pricing implications
The Inland Revenue Authority of Singapore (IRAS) published a set of “frequently asked questions” (FAQs) to address transfer pricing considerations of those taxpayers whose businesses have been affected by the coronavirus (COVID-19) pandemic.
The first part of the IRAS guidance addresses options that may be available to taxpayers in relation to the preparation of transfer pricing documentation if their business operations have been severely affected by the COVID-19 pandemic.
Other parts of the guidance relate to the impact of the COVID-19 pandemic situation on advance pricing arrangement (APA) applications—whether new or currently under review—as well as on existing APAs arising as a result of COVID-19.
Given that businesses may have been affected differently by the COVID-19 pandemic situation, IRAS acknowledged that there could be significant and varying implications for the transfer pricing positions of different taxpayers. Most notably, IRAS indicated that taxpayers may apply multi-year testing (generally over three years, that is, by using a three-year weighted average margin over FY 2018 to 2020) rather than annual testing, for the Year of Assessment (YA) 2021. This is a one-off concession that may help smooth out certain volatile results from the COVID-19 pandemic. In general, multi-year testing is only allowed under exceptional circumstances and after consultation with IRAS.
Read an October 2020 report [PDF 208 KB] prepared by the KPMG member firm in Singapore
The KPMG name and logo are trademarks used under license by the independent member firms of the KPMG global organization. KPMG International Limited is a private English company limited by guarantee and does not provide services to clients. No member firm has any authority to obligate or bind KPMG International or any other member firm vis-à-vis third parties, nor does KPMG International have any such authority to obligate or bind any member firm. The information contained herein is of a general nature and is not intended to address the circumstances of any particular individual or entity. Although we endeavor to provide accurate and timely information, there can be no guarantee that such information is accurate as of the date it is received or that it will continue to be accurate in the future. No one should act on such information without appropriate professional advice after a thorough examination of the particular situation. For more information, contact KPMG's Federal Tax Legislative and Regulatory Services Group at: + 1 202 533 4366, 1801 K Street NW, Washington, DC 20006.